Table 1. Inhibition of p38α and PBMC Cytokine Release by 5-Aryl-2-(phenylthio)-6H-pyrimido[1,6-b]pyridazin-6-ones.
compd | R1 | R2 | R3 | R4 | p38α IC50 (μM)a | PBMC IL-1β IC50b (μM) | PBMC TNFα IC50b (μM) |
---|---|---|---|---|---|---|---|
10 | Cl | H | H | Cl | 5 | 20 | 20 |
11 | H | H | H | H | >20 | NDc | ND |
12 | Me | H | H | H | 4.4 | 3.5 | 9.7 |
13 | OMe | H | H | H | 12 | 2.8 | >20 |
14 | CF3 | H | H | H | 11 | 2.1 | >20 |
15 | Cl | H | H | H | 4.1 | 5.0 | 19.9 |
16 | H | H | H | F | >20 | 15 | >20 |
17 | H | H | H | OMe | >20 | 20 | >20 |
18 | H | H | Cl | Cl | >20 | >20 | >20 |
19 | CF3 | F | H | H | 1.7 | 1.0 | 3.1 |
20 | F | F | H | H | 3.5 | 3.7 | 15.3 |
21 | Cl | Cl | H | H | 0.25 | 0.40 | 0.46 |
Assayed according to ref (22).
See Supporting Information for assay details.
ND = not determined.